The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Synthetic Blood Substitutes And Blood Products Market During The Forecast Period 2026–2030?
The synthetic blood substitutes and blood products market size has experienced rapid expansion in recent years. This market is set to expand from $7.6 billion in 2025 to $8.81 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. The historical growth of this market can be attributed to factors such as blood donation shortages, the demand stemming from trauma and surgical needs, the risks associated with transfusion-transmitted infections, an increase in cardiovascular surgeries, and military medical requirements.
The market for synthetic blood substitutes and blood products is projected to experience substantial expansion in the coming years. This market is set to reach $15.7 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.6%. Key factors driving this anticipated growth include an increase in trauma incidents, surgical procedures for an aging demographic, advancements in recombinant factors, the need for universal blood substitutes, and strategic investments in emergency preparedness. Significant developments expected during this period encompass the creation of oxygen-carrying blood substitutes, alternative solutions for emergency trauma blood, a decrease in reliance on donor blood, the availability of blood products with longer shelf lives, and their integration into military and disaster medical practices.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21294&type=smp
What Drivers Are Expected To Influence The Synthetic Blood Substitutes And Blood Products Market During The Forecast Period?
The increasing occurrence of chronic diseases is anticipated to drive the future expansion of the synthetic blood substitutes and blood products market. Chronic diseases are long-term conditions that can be managed but not cured, often lasting for a year or more and requiring continuous medical attention. This growing prevalence can be linked to factors such as an aging demographic, unhealthy lifestyle choices, and extended life expectancy. Synthetic blood substitutes and blood products are crucial in addressing chronic disease prevalence by mitigating challenges like blood loss, anaemia, and issues with organ function, which frequently affect patients with these conditions. For example, in March 2025, the Office for Health Improvement & Disparities (OHID), a UK-based entity within the Department of Health and Social Care, reported that the GP recorded type 2 diabetes prevalence in adults aged 17 and over in England was 7.0% in March 2024, marking an increase from 6.8% in March 2023. Hence, the rising prevalence of chronic diseases is a significant growth driver for the synthetic blood substitutes and blood products market.
What Market Segments Are Evaluated Within The Synthetic Blood Substitutes And Blood Products Market?
The synthetic blood substitutes and blood products market covered in this report is segmented –
1) By Type: Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander
2) By Application: Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Other Applications
3) By End-User: Hospitals And Clinics, Blood Banks, Other End users
Subsegments:
1) By Perfluorocarbon Based Product (PFC): Emulsion-Based Products, Non-Emulsion-Based Products
2) By Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products, Crosslinked Hemoglobin-Based Products
3) By Synthetic Platelet: Platelet Substitutes, Platelet Aggregation Inhibitors
4) By Recombinant Factor: Recombinant Factor VIII, Recombinant Factor IX, Other Recombinant Factors
5) By Blood Expander: Colloid Solutions, Crystalloid Solutions
What Industry Trends Are Redefining The Synthetic Blood Substitutes And Blood Products Market?
Major companies operating in the synthetic blood substitutes and blood products market are prioritizing the creation of innovative products, such as lab-grown blood vessels, to advance emergency medical care, improve outcomes in trauma treatment, and address the global shortage of donor blood and tissues. Lab-grown blood vessels are artificial blood conduits engineered from human or synthetic cells, crafted to mimic the structure and function of natural arteries and veins for medical applications including trauma repair, dialysis, and cardiovascular surgery. For instance, in December 2024, Humacyte Global, Inc., a US-based clinical-stage biotechnology platform company, received US Food and Drug Administration (FDA) approval for Symvess, an off-the-shelf, bioengineered blood vessel implant for trauma patients needing urgent revascularization, offering a safer alternative to vein harvesting or synthetic grafts. Symvess, designed for universal use, restores blood flow and preserves limbs after severe injuries.
Who Are The Top Market Participants Influencing The Synthetic Blood Substitutes And Blood Products Market?
Major companies operating in the synthetic blood substitutes and blood products market are Takeda Pharmaceutical Company Limited, Fresenius Kabi AG, Baxter International Inc., Octapharma AG, Green Cross Corporation, Alliance Pharmaceutical Corporation, Hemosol Inc., Sanguine Corporation, Sangart Inc., Biopure Corporation, Tenex Therapeutics, Velico Medical, Hemarina S.A., KaloCyte Inc., Aurum Biosciences Limited, SpheriTech Limited, Dendritech Inc., HbO2 Therapeutics LLC, HemoBioTech Inc., Somatogen Inc.
Read the full synthetic blood substitutes and blood products market report here:
Which Region Is Forecast To Lead The Synthetic Blood Substitutes And Blood Products Market In Terms Of Market Size?
North America was the largest region in the synthetic blood substitutes and blood products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic blood substitutes and blood products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Synthetic Blood Substitutes And Blood Products Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=21294&type=smp
Browse Through More Reports Similar to the Global Synthetic Blood Substitutes And Blood Products Market 2026, By The Business Research Company
Blood Processing Devices And Consumables Market Report 2026
Blood Preparation Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-preparation-global-market-report
Blood Plasma Derivatives Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model